Intravenous Versus Subcutaneous Dosing of Epoetin: A Review of the Literature
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference26 articles.
1. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial;Eschbach;N Engl J Med,1987
2. Pharmacokinetics of recombinant human erythropoietin (rHuEPO) administered to hemodialysis (HD) patients;Egrie;Kidney Int,1988
3. Pharmacokinetics of recombinant human erythropoietin after SC administration and in longterm IV treatment in patients on maintenance hemodialysis;Neumayer;Contrib Nephrol,1989
4. Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD;Macdougall;A rationale for treatment. Contrib Nephrol,1989
5. Correction of the anaemia of chronic renal failure with erythropoietin: Pharmacokinetic studies in patients on haemodialysis and CAPD;Hughes;Contrib Nephrol,1989
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Model Development;Pharmaceutical Research;2021-04
2. Controlled delivery of follicle-stimulating hormone in cattle;International Journal of Pharmaceutics;2020-11
3. Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?;Cureus;2020-09-10
4. Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients;Canadian Journal of Kidney Health and Disease;2020-01
5. Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins;Journal of Pharmaceutical Sciences;2018-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3